NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom's Macroglobulinemia [Yahoo! Finance]
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its price target raised by analysts at HC Wainwright from $30.00 to $35.00. They now have a "buy" rating on the stock.
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $35.00 price target on the stock.
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
Form 4 Nurix Therapeutics, Inc. For: Jan 02 Filed by: Ring Christine
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
Form 8-K Nurix Therapeutics, Inc. For: Dec 09
Form SCHEDULE 13G Nurix Therapeutics, Inc. Filed by: FMR LLC
Form 4 Nurix Therapeutics, Inc. For: Dec 02 Filed by: Ring Christine
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.